How is Juvenile Rheumatoid Arthritis Treated?

Juvenile rheumatoid arthritis (JRA) has been replaced by the current diagnostic term “juvenile idiopathic arthritis” (JIA), which now encompasses all forms of arthritis occurring in children. This condition poses a serious threat to children’s health, necessitating early detection and prompt treatment. So, how is juvenile rheumatoid arthritis treated?

Treatment of Juvenile Rheumatoid Arthritis

Treatment of pediatric rheumatic diseases requires long-term management to prevent joint deformities. The primary treatment approaches are as follows:
• Pharmacotherapy: Disease-modifying antirheumatic drugs (DMARDs) form the cornerstone of treatment. Nonsteroidal anti-inflammatory drugs (NSAIDs) are used concomitantly to alleviate pain—commonly aspirin. In severe cases, corticosteroids may be required, often combined with immunosuppressive agents.
• Lifestyle management: Adequate rest is essential, and activities that place excessive stress on affected joints should be minimized. Physical therapy—including heat application—may be employed to improve local blood circulation.
• Surgical intervention: In cases of severe, established joint deformity, corrective surgery may be considered in adulthood.

Juvenile rheumatoid arthritis—the most common form of chronic arthritis in children—is now classified under the broader term “juvenile idiopathic arthritis” (JIA). It is broadly categorized into three major subtypes and predominantly affects children under age 16. JIA causes joint inflammation, resulting in swelling and pain. Inflammation may involve any joint and typically persists for at least six weeks. The number of affected joints varies depending on the JIA subtype. A hallmark symptom is morning stiffness—i.e., reduced joint mobility and increased rigidity upon waking—which tends to improve gradually during the day, often resolving by midday. This diurnal pattern is characteristic of JIA.

We hope this information is helpful to you!